
Hcw Biologics
(NASDAQ) HCWB
Hcw Biologics Financials at a Glance
Market Cap
$4.25M
Revenue (TTM)
$422.02K
Net Income (TTM)
$12.05M
EPS (TTM)
$-13.96
P/E Ratio
-0.05
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.74
Volume
23,911
Open
$0.71
Price
$0.74
Volume
23,911
Open
$0.71
Previous Close
$0.74
Daily Range
$0.70 - $0.79
52-Week Range
$0.47 - $17.80
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$0.74
Volume
23,911
Open
$0.71
Previous Close
$0.74
Daily Range
$0.70 - $0.79
52-Week Range
$0.47 - $17.80
HCWB News
HCWB: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Hcw Biologics
Industry
Biotechnology
Sector
Health CareEmployees
36
CEO
Hing C. Wong, PhD
Website
www.hcwbiologics.comHeadquarters
Miramar, FL 33025, US
HCWB Financials
Key Financial Metrics (TTM)
Gross Margin
-21%
Operating Margin
-28%
Net Income Margin
-29%
Return on Equity
-27726%
Return on Capital
8%
Return on Assets
-47%
Earnings Yield
-20.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.25M
Shares Outstanding
5.76M
Volume
23.91K
Short Interest
0.00%
Avg. Volume
8.18M
Financials (TTM)
Gross Profit
$959.40K
Operating Income
$29.48M
EBITDA
$27.68M
Operating Cash Flow
$14.23M
Capital Expenditure
$261.62K
Free Cash Flow
$14.49M
Cash & ST Invst.
$4.67M
Total Debt
$13.69M
Hcw Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$15.61K
-96.3%
Gross Profit
$170.78K
-300.3%
Gross Margin
-10.94%
N/A
Market Cap
$4.25M
N/A
Market Cap/Employee
$118.10K
N/A
Employees
36
N/A
Net Income
$4.55M
-16.7%
EBITDA
$4.25M
-19.8%
Quarterly Fundamentals
Net Cash
$6.40M
+45.8%
Accounts Receivable
$30.67K
-95.3%
Inventory
$0.00
N/A
Long Term Debt
$692.53K
-89.3%
Short Term Debt
$6.81M
+7.4%
Return on Assets
-47.36%
N/A
Return on Invested Capital
8.39%
N/A
Free Cash Flow
$3.24M
-9.3%
Operating Cash Flow
$3.24M
-10.7%
